CAPPELLARI, Ornella
 Distribuzione geografica
Continente #
NA - Nord America 2.022
EU - Europa 1.007
AS - Asia 823
SA - Sud America 253
Continente sconosciuto - Info sul continente non disponibili 180
AF - Africa 40
OC - Oceania 5
Totale 4.330
Nazione #
US - Stati Uniti d'America 1.912
IT - Italia 542
SG - Singapore 318
BR - Brasile 213
CN - Cina 135
HK - Hong Kong 112
RU - Federazione Russa 93
SE - Svezia 70
VN - Vietnam 70
FR - Francia 64
DE - Germania 63
CA - Canada 55
FI - Finlandia 48
GB - Regno Unito 43
BD - Bangladesh 38
ID - Indonesia 27
IN - India 22
MX - Messico 21
AR - Argentina 14
TR - Turchia 13
CZ - Repubblica Ceca 12
NL - Olanda 12
PL - Polonia 12
ZA - Sudafrica 12
CI - Costa d'Avorio 11
IQ - Iraq 11
PK - Pakistan 11
JP - Giappone 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
CO - Colombia 8
ES - Italia 8
JO - Giordania 8
UA - Ucraina 8
CR - Costa Rica 7
CW - ???statistics.table.value.countryCode.CW??? 7
AT - Austria 6
RS - Serbia 6
AU - Australia 5
BE - Belgio 5
PH - Filippine 5
GP - Guadalupe 4
MA - Marocco 4
NI - Nicaragua 4
PE - Perù 4
TT - Trinidad e Tobago 4
EC - Ecuador 3
EE - Estonia 3
EG - Egitto 3
GT - Guatemala 3
IL - Israele 3
KG - Kirghizistan 3
KR - Corea 3
KZ - Kazakistan 3
PY - Paraguay 3
SC - Seychelles 3
VE - Venezuela 3
BS - Bahamas 2
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
MY - Malesia 2
PT - Portogallo 2
SA - Arabia Saudita 2
SV - El Salvador 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
DJ - Gibuti 1
DK - Danimarca 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
IE - Irlanda 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 4.157
Città #
Ashburn 231
San Jose 178
Singapore 159
Chandler 143
Bari 132
Hong Kong 112
Council Bluffs 103
Fairfield 88
Dallas 87
Milan 80
Nyköping 65
Beijing 56
Cambridge 44
Helsinki 42
Bitetto 38
Los Angeles 38
Houston 36
Santa Clara 36
Seattle 36
New York 34
Woodbridge 34
Rome 33
Lauterbourg 30
Bitonto 28
Jakarta 25
Lawrence 25
Wilmington 24
São Paulo 22
Des Moines 21
Inglewood 21
Taranto 21
Roxbury 19
Ann Arbor 17
Frankfurt am Main 17
Falkenstein 16
Dong Ket 15
Grottaglie 15
Hanoi 15
Ho Chi Minh City 14
Chicago 13
Naples 13
San Diego 13
Montreal 12
Abidjan 11
Boston 11
Brno 11
Buffalo 11
Munich 11
Toronto 10
London 9
Mexico City 9
Nuremberg 9
Columbus 8
Guangzhou 8
Princeton 8
Tashkent 8
Belo Horizonte 7
Brooklyn 7
Denver 7
North Bergen 7
Phoenix 7
Rio de Janeiro 7
Tokyo 7
Warsaw 7
Willemstad 7
Amman 6
Atlanta 6
Baku 6
Belgrade 6
Campinas 6
Haiphong 6
Johannesburg 6
Turku 6
Boardman 5
Brussels 5
Delhi 5
Miami 5
Miano 5
Ottawa 5
Ankara 4
Baltimore 4
Bauru 4
Brasília 4
Da Nang 4
Düsseldorf 4
Goiânia 4
Lahore 4
Managua 4
Melbourne 4
Modugno 4
Norwalk 4
Porto Alegre 4
San Francisco 4
The Dalles 4
Turin 4
Vancouver 4
Vienna 4
Wroclaw 4
Alajuela 3
Albairate 3
Totale 2.548
Nome #
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 303
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 174
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 170
"The Social Network" and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies 153
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies 153
Musculoskeletal geometry, muscle architecture and functional specialisations of the mouse hindlimb 152
Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy 150
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 143
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 138
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 137
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 136
Ion channels as biomarkers of altered myogenesis in myofiber precursors of Duchenne muscular dystrophy 133
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 130
Functional Rescue of Dystrophin Deficiency in Mice Caused by Frameshift Mutations Using Campylobacter jejuni Cas9 126
Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients 126
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks 122
Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions 119
Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse 115
A dynamic simulation of musculoskeletal function in the mouse hindlimb during trotting locomotion 106
A versatile system for neuromuscular stimulation and recording in the mouse model using a lightweight magnetically coupled headmount 103
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD) 102
Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1 101
Dll4 and PDGF-BB Convert Committed Skeletal Myoblasts to Pericytes without Erasing Their Myogenic Memory 97
Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering 91
Muscle moment arms and sensitivity analysis of a mouse hindlimb musculoskeletal model 87
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy 87
BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy 86
Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy 85
Noggin recruits mesoderm progenitors from the dorsal aorta to a skeletal myogenic fate 76
Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy 68
Pericytes in development and pathology of skeletal muscle 64
PRE-CLINICAL ASSESSMENT OF THE ROLE OF THE COMPLEMENT SYSTEM IN TRIGGERING FIBROSIS IN DUCHENNE MUSCULAR DYSTROPHY: TOWARDS NOVEL THERAPEUTIC TARGETS 54
Investigation of genotype-phenotype correlation in 2D cell models of Duchenne muscular dystrophy patients shows mutation-dependent defects in mitochondrial respiration and delay in myogenic program 50
Dll4 and PDGF-BB Convert Committed Skeletal Myoblasts to Pericytes without Erasing Their Myogenic Memory 46
A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models 43
Natural history study of the D2-mdx mouse for Duchenne muscular dystrophy: a comparison across two independent study sites 39
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model. 34
Cell lines of Duchenne Muscular dystrophy patients shows mutation-dependent delay in myogenic program 31
Patient-Oriented In Vitro Studies in Duchenne Muscular Dystrophy: Validation of a 3D Skeletal Muscle Organoid Platform 31
254PActivation of complement cascade may trigger inflammation and fibrosis in Duchenne muscular dystrophy: a preclinical investigation on two murine models 31
Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy 30
Electrical impedance myography as a tool for monitoring disease progression in mouse models of Duchenne Muscular Dystrophy: a longitudinal, multisite study 28
Best reference genes for unbiased normalized transcript expression in normal and dystrophic human cell models of myogenesis 25
Validation of 3D-muscle on chip platform for patient oriented preclinical studies in Duchenne Muscular Dystrophy 25
The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recovery 23
LKB1 Dysregulation in Duchenne Muscular Dystrophy Models: Disease Specificity and Epigenetic Control by HDAC Inhibitors 7
Totale 4.330
Categoria #
all - tutte 19.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022150 0 0 0 0 1 18 13 6 9 15 43 45
2022/2023339 29 46 30 25 40 47 9 35 49 4 11 14
2023/2024144 11 36 7 10 10 18 2 6 4 9 5 26
2024/2025745 24 2 44 18 20 86 173 72 34 58 65 149
2025/20261.714 258 90 144 127 158 63 194 52 200 175 123 130
2026/2027835 172 114 192 313 44 0 0 0 0 0 0 0
Totale 4.330